C2orf49
Ashwin
Also known as: ASHWN_HUMAN, asw, MGC5509
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BVC5
- Gene
- C2orf49
- Ensembl
- ENSG00000135974
- Chromosome
- 2
- Canonical length
- 232 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to be involved in tRNA splicing, via endonucleolytic cleavage and ligation. Located in nucleoplasm. Part of tRNA-splicing ligase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
232 residues, UniProt reviewed canonical sequence.
>Q9BVC5|C2orf49
1 MAGDVGGRSC TDSELLLHPE LLSQEFLLLT LEQKNIAVET DVRVNKDSLT DLYVQHAIPL
61 PQRDLPKNRW GKMMEKKREQ HEIKNETKRS STVDGLRKRP LIVFDGSSTS TSIKVKKTEN
121 GDNDRLKPPP QASFTSNAFR KLSNSSSSVS PLILSSNLPV NNKTEHNNND AKQNHDLTHR
181 KSPSGPVKSP PLSPVGTTPV KLKRAAPKEE AEAMNNLKPP QAKRKIQHVT WPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C2orf49 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- retina: 23 nTPM
- tongue: 20 nTPM
- ovary: 19 nTPM
- skeletal muscle: 19 nTPM
- bone marrow: 18 nTPM
- thymus: 15 nTPM
Single-cell type
- esophageal apical cells: 82 nCPM
- late primary spermatocytes: 75 nCPM
- parietal cells: 58 nCPM
- late spermatids: 56 nCPM
- syncytiotrophoblasts: 51 nCPM
- endometrial ciliated cells: 45 nCPM
Immune cell
- plasmacytoid DC: 19 nTPM
- neutrophil: 18 nTPM
- naive B-cell: 18 nTPM
- basophil: 15 nTPM
- memory B-cell: 15 nTPM
- classical monocyte: 13 nTPM
Brain region
- white matter: 28 nTPM
- cerebellum: 24 nTPM
- basal ganglia: 24 nTPM
- midbrain: 24 nTPM
- medulla oblongata: 23 nTPM
- cerebral cortex: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.02
- gnomAD missense Z
- -0.51
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ashwin
- Developmental protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of C2orf49 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C2orf49 as an antibody target. Whether an autoantibody or antibody against C2orf49 could matter depends on whether native C2orf49 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C2orf49 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label C2orf49 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...